A general class of promotion time cure rate models with a new biological interpretation

Berrino E et al (2021) High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients. ESMO Open 6:100133 Calsavara VF, Milani EA, Bertolli E, Tomazella V (2020) Long-term frailty modeling using a non-proportional hazards model: application with a melanoma dataset. Stat Methods Med Res 29:2100–2118 Chen T, Du P (2018) Promotion time cure rate model with nonparametric form of covariate effects. Stat Med 37:1625–1635 Chen M-H, Ibrahim JG, Sinha D (1999) A new Bayesian model for survival data with a surviving fraction. J Am Stat Assoc 94:909–919 Cooner F, Banerjee S, Carlin BP, Sinha D (2007) Flexible cure rate modeling under latent activation schemes. J Am Stat Assoc 102:560–572 Coordenação de Prevenção e Vigilância (2017). Instituto Nacional de Cancer José Alencar Gomes da Silva. Estimativa 2018: Incidência de Cancer no Brasil. Coordenação de Prevenção e Vigilância. Rio de Janeiro. http://www1.inca.gov.br/estimativa/2018/ de Andrade CT, Magedanz AMPCB, Escobosa DM, Tomaz WM, Santinho CS, Lopes TO, Lombardo V (2012) The importance of a database in the management of healthcare services. Einstein (São Paulo) 10:360–365 De Castro M, Cancho VG, Rodrigues J (2009) A Bayesian long-term survival model parametrized in the cured fraction. Biom J 51:443–455 Dunn P, Smyth G (1996) Randomized quantile residuals. J Comput Graph Stat 5:236–244 Ervik M, Lam F, Ferlay J, Mery L, Soerjomataram I, Bray F et al (2016) Cancer today Lyon, France: international agency for research on cancer. 2016. Cancer today. https://www.gco.iarc.fr/today. Accessed 01/02/2019 Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur GA et al (2017) Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67:472–492 Gómez YM, Gallardo DI, Leão J, Calsavara VF (2021) On a new piecewise regression model with cure rate: diagnostics and application to medical data. Stat Med 40(29):6723–6742 Gupta RC, Gupta PL, Gupta RD (1998) Modeling failure time data by Lehman alternatives. Commun Stat Theory Methods 27:887–904 Hanin L, Huang L (2014) Identifiability of cure models revisited. J Multivar Anal 130(1):261–274 Kalbfleisch JD, Prentice RL (2002) The statistical analysis of failure time data, 2nd edn. Wiley, New York Kim S, Chen MH, Dey DK (2011) A new threshold regression model for survival data with a cure fraction. Lifetime Data Anal 17:101–122 Leão J, Bourguignon M, Saulo H, Santos-Neto M, Calsavara V (2021) The negative binomial beta prime regression model with cure rate: application with a melanoma dataset. J Stat Theory Pract 15(3):1–21 Li CS, Taylor JM, Sy JP (2001) Identifiability of cure models. Stat Probab Lett 54(4):389–395 Molina KC, Calsavara VF, Tomazella VD, Milani EA (2021) Survival models induced by zero-modified power series discrete frailty: application with a melanoma data set. Stat Methods Med Res 29(8):2100–2118 Puglisi R et al (2021) Biomarkers for diagnosis, prognosis and response to immunotherapy in melanoma. Cancers (Basel) 13:2875 R Core Team (2020) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. http://www.R-project.org/ Rigby RA, Stasinopoulos DM (2005) Generalized additive models for location, scale and shape, (with discussion). Appl Stat 54(3):507–554 Rodrigues J, de Castro M, Cancho V, Balakrishnan N (2009) COM-Poisson cure rate survival models and an application to a cutaneous melanoma data. J Stat Plan Inference 139:3605–3611 Rodrigues J, de Castro M, Balakrishnan N (2011) Destructive weighted Poisson cure rate models. Lifetime Data Anal 2011(17):333–346 Rodrigues J, Cordeiro GM, Cancho VG, Balakrishnan N (2016) Relaxed Poisson cure rate models. Biom J 58:397–415 Rodrigues AS, Calsavara VF, Bertolli E, Peres SV, Tomazella VL (2021) Bayesian long-term survival model including a frailty term: application to melanoma data. Chil J Stat 12(1):53–70 Shain AH, Bastian BC (2016) From melanocytes to melanomas. Nat Rev Cancer 16:345–358 Stasinopoulos D, Rigby R (2007) Generalized additive models for location scale and shape (GAMLSS) in R. J Stat Softw 23:1–46 Tournoud M, Ecochard R (2007) Application of the promotion time cure model with time-changing exposure to the study of HIV/AIDS and other infectious diseases. Stat Med 26:1008–1021 Tournoud M, Ecochard R (2008) Promotion time models with timechanging exposure and heterogeneity: application to infectious diseases. Biom J 50:395–407 Tucker S, Thames H, Taylor J (1990) How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics? Radiat Res 24:273–282 Wimme G, Altman G (1996) The multiple Poisson distribution, its characteristics and a variety of forms. Biom J 38:995–1011 Yakovlev AY, Tsodikov AD (1996) Stochastic model of tumor latency and their biostatistical applications. World Scientific, Singapore Yin G, Ibrahim J (2005) A general class of Bayesian survival models with zero and nonzero cure fractions. Biometrics 61:403–412